A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
Year: 2005
Type: article
Study design: Clinical Trial
Institutions: Goethe University Frankfurt, German Breast Group, University Hospital Frankfurt, University Hospital Schleswig-Holstein, Universitätsklinikum Erlangen, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Medizinische Hochschule Hannover, Klinikum Magdeburg, Rotkreuzklinikum München, AstraZeneca (Germany), University Hospital Heidelberg, Frauenklinik Heidelberg
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2012300394
